Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Why Brand-Name Cant Match Price Structural Barriers: Public Company Obligations: Must maximize shareholder return Quarterly earnings pressure Executive compensation tied to profits Cant dramatically reduce price without stock impact Sunk Costs: Billions invested in development Need to recoup investment Justify to shareholders and board Complex Distribution System: PBMs demand rebates Wholesalers take cut Pharmacy margins Cant easily change system Market Dynamics: Limited competition (patent protection) Can charge premium prices Demand exceeds supply No pressure to reduce Eli Lilly unlikely to reduce tirzepatide prices significantly while patents protected
Sisley S, Gutierrez-Aguilar R, Scott M, DAlessio DA, Sandoval DA, Seeley RJ
Injectable vs Oral Clearance The method by which BPC-157 is delivered injectable vs oral significantly influences how its absorbed, how long it stays active in the body, and how quickly it clears your system
our expectations surrounding potential regulatory submissions, progress, or approvals and timing thereof for any of our product candidates
US$ 23.59
US$ 26.86
US$ 21.43
US$ 25.70
US$ 28.53
US$ 23.96
US$ 24.07
US$ 26.77
